 |
 |
Editor-in-Chief |
| |
 |
Paul Chrisp |
|
International
editorial board |
| |
|
The editorial board for Core
Evidence comprises an expanding group of experts and opinion
leaders representing clinical practice in the major therapy
areas, formulary management, evidence-based medicine and outcomes
research |
|
Peer reviewed |
|
Core Evidence is included
in EMBASE, EMNursing, Scopus, the Health Economic Evaluations
Database (HEED), and CINAHL. Indexing in all other major databases
is being applied for |
| Core Evidence
is the first international peer-reviewed journal to rigorously
evaluate the evidence for rational drug selection based on outcomes
central to informed medical decision making, with the goal of
improved quality of care |
| Core Evidence
is unique because it: |
|
Focuses on clinical outcomes evidence |
|
Reviews the emerging
evidence at key stages of drug development and
evaluates how this may affect a drug’s place in therapy |
|
Conducts a rigorous review
of the evidence based on: |
| |
|
Relevance: formulary guideline requirements
provide the structure |
| |
|
Validity: evidence-based medicine techniques
evaluate the evidence |
| |
|
Credibility: input from international
experts weights the evidence according to clinical relevance |
| |
|
|
